(Q51763955)
Statements
Safety and pharmacokinetics of subcutaneously administered rilonacept in patients with well-controlled end-stage renal disease (ESRD). (English)
1 reference
Allen Radin
1 reference
Thomas Marbury
1 reference
Greg Osgood
1 reference
Pavel Belomestnov
1 reference
24 December 2009
1 reference
50
1 reference
7
1 reference
835-841
1 reference
1 reference
1 reference
1 reference